Prevention of thromboembolism in total hip replacement: Aspirin versus dihydroergotamine-heparin
DOI:
https://doi.org/10.3109/17453678709146500Abstract
In a prospective and controlled study, we compared the prophylactic effect of high-dose acetylsalicylic acid (ASA) and dihydroergotamine-heparin (DHEH) in 82 patients over 50 years of age undergoing total hip replacement. The patients were screened by pulmonary scan and 1251 fibrinogen uptake. Phlebography was done if the 125I fibrinogen test was positive. According to our criteria, thromboembolism developed in 9 of 40 receiving ASA and in 5 of 42 patients receiving DHEH. The effect of ASA was limited to men; in 16 men on this therapy, none had thromboembolism versus 9 of 24 women. Twenty-two patients showed wound hematomas, but none needed surgical intervention.Downloads
Download data is not yet available.
Downloads
Published
1987-01-01
How to Cite
Josefsson, G., Dahlqvist, A., & Bodfors, B. (1987). Prevention of thromboembolism in total hip replacement: Aspirin versus dihydroergotamine-heparin. Acta Orthopaedica, 58(6), 626–629. https://doi.org/10.3109/17453678709146500
Issue
Section
Articles
License
Acta Orthopaedica (Scandinavica) content is available freely online as from volume 1, 1930. The journal owner owns the copyright for all material published until volume 80, 2009. As of June 2009, the journal has however been published fully Open Access, meaning the authors retain copyright to their work. As of June 2009, articles have been published under CC-BY-NC or CC-BY licenses, unless otherwise specified.
